The key role of MSH2, Chloride Channel Accessory 2 (CLCA2), and Patched 2 (PTCH2), in the resistance of glioblastoma cells to temozolomide was elucidated using genome-wide CRISPR/Cas9 screen technology [66]. The gene discussed is CLCA2; the disease is glioblastoma.